{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:12:47Z","timestamp":1793722367535,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012591","name":"Program for Liaoning Innovative Talents in University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejps.2025.107033","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:05:39Z","timestamp":1738757139000},"page":"107033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Exploration of enalapril-lacidipine co-amorphous system with superior dissolution, in vivo absorption and physical stability via incorporated into mesoporous silica"],"prefix":"10.1016","volume":"207","author":[{"given":"Yuhan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangce","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiya","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107033_bib0001","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/pharmaceutics16050575","article-title":"Investigating the influence of processing conditions on dissolution and physical stability of solid dispersions with fenofibrate and mesoporous silica","volume":"16","author":"Baumgartner","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107033_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106015","article-title":"Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery","volume":"167","author":"Baumgartner","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123946","article-title":"High loading of lipophilic compounds in mesoporous silica for improved solubility and dissolution performance","volume":"654","author":"Benedikt Brenner","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0004","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/j.xphs.2017.06.005","article-title":"The binary system of ibuprofen-nicotinamide under nanoscale confinement: from cocrystal to coamorphous state","volume":"106","author":"Bi","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0005","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/acs.molpharmaceut.1c00288","article-title":"Influence of adsorption state and molecular interaction on physical stability of confined amorphous vortioxetine","volume":"18","author":"Cao","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119105","article-title":"Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy","volume":"578","author":"Chen","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2008.06.022","article-title":"Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation","volume":"71","author":"Chieng","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","volume":"100","author":"Dengale","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107033_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/adt.2023.023","article-title":"Formulation and characterization of nanoparticulate drug carrier system for lacidipine","volume":"21","author":"Dessai","year":"2023","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107033_bib0010","article-title":"Turmeric extract-loaded polyvinylpyrrolidone spherical submicron particles produced using electrohydrodynamic atomization: their physico-chemical properties and antioxidant activity","volume":"6","author":"Dewi","year":"2019","journal-title":"Mater. Res. Express"},{"key":"10.1016\/j.ejps.2025.107033_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2017.04.015","article-title":"Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways","volume":"256","author":"Edueng","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107033_bib0012","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3390\/pharmaceutics15122653","article-title":"Genistein co-amorphous systems with amino acids: An investigation into enhanced solubility and biological activity","volume":"15","author":"Garbiec","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107033_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.xphs.2017.05.039","article-title":"Hot melt extrusion as solvent-free technique for a continuous manufacturing of drug-loaded mesoporous silica","volume":"107","author":"Genina","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0014","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijpharm.2019.06.010","article-title":"Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion","volume":"566","author":"Guan","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejps.2017.12.028","article-title":"Alginate as a potential diphase solid dispersion carrier with enhanced drug dissolution and improved storage stability","volume":"114","author":"Guan","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0016","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/pharmaceutics13101725","article-title":"Deaggregation and crystallization inhibition by small amount of polymer addition for a co-amorphous curcumin-magnolol system","volume":"13","author":"Han","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107033_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122644","article-title":"Mechanistic insight into gel formation of co-amorphous resveratrol and piperine during dissolution process","volume":"634","author":"Han","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/02652048.2019.1579265","article-title":"Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles","volume":"36","author":"Hashim Ali","year":"2019","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2025.107033_bib0019","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2019.02.028","article-title":"Glabridin smartPearls - Silica selection, production, amorphous stability and enhanced solubility","volume":"561","author":"Hespeler","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105103","article-title":"Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin","volume":"142","author":"Ibrahim","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejps.2005.06.009","article-title":"Release evaluation of drugs from ordered three-dimensional silica structures","volume":"26","author":"Izquierdo-Barba","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0022","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2018.09.024","article-title":"In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine","volume":"132","author":"Kasten","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1872211314666200117094406","article-title":"An overview on recent patents and technologies on solid dispersion","volume":"14","author":"Kaushik","year":"2020","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ejps.2025.107033_bib0024","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/pharmaceutics13081318","article-title":"Recent technologies for amorphization of poorly water-soluble drugs","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107033_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17425247.2016.1198770","article-title":"Rational excipient selection for co-amorphous formulations","volume":"14","author":"Korhonen","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107033_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124676","article-title":"Hot melt extruded high-dose amorphous solid dispersions containing lumefantrine and soluplus","volume":"665","author":"Li","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0027","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17425247.2019.1575806","article-title":"Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery","volume":"16","author":"Li","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107033_bib0028","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1021\/acs.molpharmaceut.0c00042","article-title":"Determination of the optimal molar ratio in amino acid-based coamorphous systems","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0029","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/mp2002973","article-title":"Coamorphous drug systems: Enhanced physical stability and dissolution rate of indomethacin and naproxen","volume":"8","author":"L\u00f6bmann","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2017.07.047","article-title":"Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs","volume":"262","author":"Maleki","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107033_bib0031","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/17425247.2016.1100165","article-title":"Mesoporous silica formulation strategies for drug dissolution enhancement: a review","volume":"13","author":"McCarthy","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ejps.2025.107033_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123784","article-title":"Dasatinib loaded mucoadhesive lecithin-chitosan hybrid nanoparticles for its augmented oral delivery, in-vitro efficacy and safety","volume":"651","author":"Mehandole","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0033","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.micromeso.2009.10.026","article-title":"Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material","volume":"130","author":"Mellaerts","year":"2010","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.ejps.2025.107033_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2019.03.049","article-title":"Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide","volume":"563","author":"Mura","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119492","article-title":"Degrees of order: A comparison of nanocrystal and amorphous solids for poorly soluble drugs","volume":"586","author":"Peltonen","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0036","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2010.12.035","article-title":"Carvedilol dissolution improvement by preparation of solid dispersions with porous silica","volume":"406","author":"Planin\u0161ek","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105113","article-title":"Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation","volume":"141","author":"Price","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0038","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acs.molpharmaceut.1c00606","article-title":"Nanoconfinement of a pharmaceutical cocrystal with praziquantel in mesoporous silica: the influence of the solid form on dissolution enhancement","volume":"19","author":"Salas-Z\u00fa\u00f1iga","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118498","article-title":"Is prodrug design an approach to increase water solubility?","volume":"568","author":"Sanches","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2011.03.018","article-title":"Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size","volume":"410","author":"Shen","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0041","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/molecules21040509","article-title":"Properties of the sodium naproxen-lactose-tetrahydrate co-crystal upon processing and storage","volume":"21","author":"Sovago","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107033_bib0042","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2016.01.062","article-title":"Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions","volume":"503","author":"Sun","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0043","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3390\/pharmaceutics14102203","article-title":"Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization","volume":"14","author":"Tambe","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107033_bib0044","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/acs.molpharmaceut.2c00057","article-title":"Design of a stable coamorphous system using lactose as an antiplasticizing agent for diphenhydramine hydrochloride with a low glass transition temperature","volume":"19","author":"Ueda","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119662","article-title":"Formulation of co-amorphous systems from naproxen and naproxen sodium and in situ monitoring of physicochemical state changes during dissolution testing by Raman spectroscopy","volume":"587","author":"Ueda","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0046","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1021\/acs.molpharmaceut.8b00174","article-title":"Application of a salt coformer in a co-amorphous drug system dramatically enhances the glass transition temperature: A case study of the ternary system carbamazepine, citric acid, and l-arginine","volume":"15","author":"Ueda","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0047","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1002\/anie.200604488","article-title":"Mesoporous materials for drug delivery","volume":"46","author":"Vallet-Reg\u00ed","year":"2007","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.ejps.2025.107033_bib0048","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2010.09.002","article-title":"Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica","volume":"41","author":"Van Speybroeck","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0050","article-title":"Polymeric solid dispersion Vs co-amorphous technology: A critical comparison","volume":"78","author":"Vullendula","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107033_bib0051","first-page":"95","article-title":"Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability","volume":"14","author":"Wang","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107033_bib0052","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2017.08.078","article-title":"Importance of in vitro dissolution conditions for the in vivo predictability of an amorphous solid dispersion containing a pH-sensitive carrier","volume":"531","author":"Wendelboe","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0053","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1208\/s12249-018-1134-9","article-title":"Lacidipine amorphous solid dispersion based on hot melt extrusion: Good miscibility, enhanced dissolution, and favorable stability","volume":"19","author":"Xi","year":"2018","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2025.107033_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2024.08.027","article-title":"Solubilization techniques used for poorly water-soluble drugs","author":"Xie","year":"2024","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.ejps.2025.107033_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2023.02.015","article-title":"Thermal investigation on hydrated co-amorphous systems of nicotinamide and prilocaine","volume":"186","author":"Xu","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107033_bib0056","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/pharmaceutics14020428","article-title":"Superiority of mesoporous silica-based amorphous formulations over spray-dried solid dispersions","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T14:46:33Z","timestamp":1740667593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":55,"alternative-id":["S0928098725000326"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107033","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of enalapril-lacidipine co-amorphous system with superior dissolution, in vivo absorption and physical stability via incorporated into mesoporous silica","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107033"}}